SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ATLAB Pharma SAS Release: Favorable Safety Profile and Antitumor Activity of ATL101 (Lutetium-177 Anti-PSMA Antibody) in Castration-Resistant Prostate Cancer Patients Presented at American Society of Clinical Oncology GU 2013